Revolution Medicines Inc [RVMD] stock is trading at $80.06, up 0.53%. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The RVMD shares have gain 5.62% over the last week, with a monthly amount glided 30.43%, and seem to be holding up well over a long-time horizon.
From an analyst’s perspective:
Revolution Medicines Inc [NASDAQ: RVMD] stock has seen the most recent analyst activity on November 18, 2025, when Wolfe Research initiated its Outperform rating and assigned the stock a price target of $75. Previously, RBC Capital Mkts started tracking the stock with Outperform rating on November 03, 2025, and set its price target to $77. On October 21, 2025, Mizuho initiated with a Outperform rating and assigned a price target of $90 on the stock. Truist started tracking with a Buy rating for this stock on September 05, 2025, and assigned it a price target of $99. In a note dated August 19, 2025, Piper Sandler initiated an Overweight rating and provided a target price of $75 on this stock.
Revolution Medicines Inc [RVMD] stock has fluctuated between $29.17 and $79.82 over the past year. Currently, Wall Street analysts expect the stock to reach $82 within the next 12 months. Revolution Medicines Inc [NASDAQ: RVMD] shares were valued at $80.06 at the most recent close of the market. An investor can expect a potential return of 2.42% based on the average RVMD price forecast.
Analyzing the RVMD fundamentals
To continue investigating profitability, this company’s Return on Assets is posted at -0.43, Equity is -0.49 and Total Capital is -0.52. Upon thorough examination of the company’s fundamental financial framework, it becomes apparent that the debt-to-equity ratio stands at 0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 78.66 points at the first support level, and at 77.26 for the second support level. However, for the 1st resistance point, the stock is sitting at 81.47, and for the 2nd resistance point, it is at 82.89.
Ratios To Look Out For
For context, Revolution Medicines Inc’s Current Ratio is 8.05. Further, the Quick Ratio stands at 8.05, while the Cash Ratio is 0.89.
Transactions by insiders
Recent insider trading involved Anders Jack, Chief Financial Officer, that happened on Nov 25 ’25 when 5418.0 shares were sold. GOLDSMITH MARK A completed a deal on Nov 25 ’25 to sell 60000.0 shares. Meanwhile, GOLDSMITH MARK A sold 6000.0 shares on Nov 25 ’25.
